Canadian Association of General Surgeons and American College of Surgeons evidence-based reviews in surgery. 27. Quality-of-life outcomes with sentinel node biopsy versus standard axillary treatment in patients with operable breast cancer

Canadian Journal of Surgery

Volumn 51, Issue 6, 2008, Pages 483-485

  Latosinsky, Steve ^b   Dabbs, Kelly ^b   Moffat, Frederick ^b   McKenzie, M E ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57149111981     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-93.
2. Duric V, Stockler M. Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. Lancet Oncol 2001;2:691-7.
3. Harlow SP, Krag DN, Julian TB, et al. Pre-randomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically nodenegative breast cancer. Ann Surg 2005;241:48-54.